Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12188/29864| Title: | SODIUM-GLUCOSE CO-TRANSPORTER 2 INHIBITORS IN HEART FAILURE | Authors: | Georgiev, Antonio Tonev, Jelena Jovanovski Srceva, Marija Nikolov, Igor Jankulovska, Anamarija Manev, Nikola Mitevski, Goran |
Keywords: | SGLT2 inhibitors mechanism of action heart failure |
Issue Date: | 2023 | Publisher: | MIT University Skopje | Journal: | International Journal of Recent Research in Arts and Sciences | Abstract: | Sodium-glucose co-transporter 2 (SGLT-2) inhibitors are antidiabetic drugs whose therapeutic action has gone beyond diabetes and extended to the cardiovascular and renal systems. They are class I evidence, guideline-directed medical therapy in heart failure irrespective of ejection fraction or diabetes mellitus. There are several assumptions about the mechanism of their action, but the exact mechanism has not yet been determined. Every doctor should be familiar with these new drugs for the implementation of their uses and better recognize and limit side effects. | URI: | http://hdl.handle.net/20.500.12188/29864 |
| Appears in Collections: | Faculty of Medicine: Journal Articles |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| IJRRAS_vol.17_2023.pdf | 4.86 MB | Adobe PDF | View/Open |
Page view(s)
19
checked on May 21, 2024
Download(s)
2
checked on May 21, 2024
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.